Cannabis Pharmacy: The Practical Guide to Medical Marijuana
Format: PDF / Kindle (mobi) / ePub
There are currently 4.2 million medical cannabis patients in the United States, and there are 20 states plus the District of Columbia where medical cannabis is legal. As medical cannabis becomes an accepted herbal medicine, there is a demand for clear, easy-to-follow information for the layperson based on the latest sound medical and evidence-based research.
Written by Michael Backes, a respected expert in the field, Cannabis Pharmacy begins with the history of medical marijuana and an explanation of how cannabis works with the body's own endocannabinoid system. Backes goes on to explore in detail 27 of the most popular cannabis varieties, how to identify them, the differences between them, and the medical conditions for which patients have reported effectiveness. Additional chapters describe how to prepare and store cannabis, how best to administer those preparations, and how to modify and control dosage. Also included is a guide to 29 ailments and illnesses for which doctors commonly recommend medical marijuana, including chronic pain, chemotherapy-induced nausea, multiple sclerosis, Alzheimer's disease, fibromyalgia, and Parkinson's disease.
Meticulously researched and written in an easy and accessible style, Cannabis Pharmacy provides the clearest, most complete, and most practical information available on the use and benefits of medical marijuana.
Benefits of Cannabis in Migraine, Fibromyalgia, Irritable Bowel Syndrome and Other Treatment-Resistant Conditions?,” Neuroendocrinology Letters 25, nos. 1–2 (2004): 31–39. 125 Sunil K. Aggarwal, “Cannabinergic Pain Medicine: A Concise Clinical Primer and Survey of Randomized-Controlled Trial Results,” Clinical Journal of Pain 29, no. 2 (2013): 162–71. 126 Ethan B. Russo and Andrea G. Hohmann, “Role of Cannabinoids in Pain Management,” in Comprehensive Treatment of Chronic Pain by Medical,
dx.doi.org/10.1016/j.biopsych.2005.01.026. 200 J. Jacobus, S. Bava, M. Cohen-Zion, O. Mahmood, and S. F. Tapert, “Functional Consequences of Marijuana Use in Adolescents,” Pharmacology Biochemistry and Behavior 92, no. 4 (2009): 559–65, doi:10.1016/j.pbb.2009.04.001. 201 An abstract of the Stanford survey that was supervised by Dr. Brenda Porter was presented at the “Curing the Epilepsies” meeting of the National Institute of Neurological Disorders and Stroke, held from April 17–19, 2013. 202
Di Marzo, Vincenzo, Fabiana Piscitelli, and Raphael Mechoulam. “Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes.” Handbook of Experimental Pharmacology, 203 (2011): 75–104. Doblin, Richard E., and M. A. Kleiman. “Marijuana as Antiemetic Medicine: A Survey of Oncologists’ Experiences and Attitudes.” Journal of Clinical Oncology 9, no. 7 (1991): 1314–19. Eichler, Martin, L. Spinedi, S. Unfer-Grauwiler, M. Bodmer, C. Surber, M. Luedi, and J. Drewe. “Heat Exposure
system wherein too much anandamide circulates through the body; this might be a key underlying factor.68 DOSAGE—Patients have reported initial doses equivalent to 4 milligrams of THC, the threshold of psychoactivity. The dose can also be raised to 10 milligrams of THC. By using THC and CBD cannabis medicines in combination, some of the side effects of THC may be mitigated. CBD in doses up to 10 milligrams might be used to restore endocannabinoid tone. Methods of Ingestion ORAL—Because oral
therapeutic potential. A recent placebo-controlled study of 30 MS patients at the University of California Center for Medicinal Cannabis Research (CMCR) examined the effectiveness of smoked cannabis on MS pain and spasticity.105 Sixty percent of the participants were also taking antispasticity medications and 70 percent were undergoing disease-modifying treatments such as interferon. They continued these treatments during the study. Nearly 80 percent of the participants had used cannabis